Literature DB >> 24914194

Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction.

Giulianna R Borges1, Donald A Morgan1, Pimonrat Ketsawatsomkron1, Aaron D Mickle1, Anthony P Thompson1, Martin D Cassell1, Durga P Mohapatra1, Kamal Rahmouni1, Curt D Sigmund2.   

Abstract

S-P467L mice expressing dominant negative peroxisome proliferator-activated receptor-γ selectively in vascular smooth muscle exhibit impaired vasodilation, augmented vasoconstriction, hypertension, and tachycardia. We hypothesized that tachycardia in S-P467L mice is a result of baroreflex dysfunction. S-P467L mice displayed increased sympathetic traffic to the heart and decreased baroreflex gain and effectiveness. Carotid arteries exhibited inward remodeling but no changes in distensibility or stress/strain. Aortic depressor nerve activity in response to increased arterial pressure was blunted in S-P467L mice. However, the arterial pressure and heart rate responses to aortic depressor nerve stimulation were unaltered in S-P467L mice, suggesting that the central and efferent limbs of the baroreflex arc remain intact. There was no transgene expression in nodose ganglion and no change in expression of the acid-sensing ion channel-2 or -3 in nodose ganglion. There was a trend toward decreased expression of transient receptor potential vanilloid-1 receptor mRNA in nodose ganglion, but no difference in the immunochemical staining of transient receptor potential vanilloid-1 receptor in the termination area of the left aortic depressor nerve in S-P467L mice. Although there was no difference in the maximal calcium response to capsaicin in cultured nodose neurons from S-P467L mice, there was decreased desensitization of transient receptor potential vanilloid-1 receptor channels. In conclusion, S-P467L mice exhibit baroreflex dysfunction because of a defect in the afferent limb of the baroreflex arc caused by impaired vascular function, altered vascular structure, or compromised neurovascular coupling. These findings implicate vascular smooth muscle peroxisome proliferator activated receptor-γ as a critical determinant of neurovascular signaling.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  baroreflex; blood pressure; heart rate; muscle, smooth, vascular; peroxisome proliferator-activated receptors; sympathetic nervous system

Mesh:

Substances:

Year:  2014        PMID: 24914194      PMCID: PMC4134389          DOI: 10.1161/HYPERTENSIONAHA.114.03553

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

Review 1.  Chronic activation of the baroreflex and the promise for hypertension therapy.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Handb Clin Neurol       Date:  2013

2.  Impaired baroreflex sensitivity in subjects with impaired glucose tolerance, but not isolated impaired fasting glucose.

Authors:  Jin-Shang Wu; Feng-Hwa Lu; Yi-Ching Yang; Shei-Hsi Chang; Ying-Hsiang Huang; Jia-Jin Jason Chen; Chih-Jen Chang
Journal:  Acta Diabetol       Date:  2014-01-10       Impact factor: 4.280

Review 3.  Functional organization of central pathways regulating the cardiovascular system.

Authors:  R A Dampney
Journal:  Physiol Rev       Date:  1994-04       Impact factor: 37.312

4.  Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.

Authors:  Chiara Marchesi; Asia Rehman; Yohann Rautureau; Daniel A Kasal; Marie Briet; Avshalom Leibowitz; Stefania M C Simeone; Talin Ebrahimian; Mario F Neves; Stefan Offermanns; Frank J Gonzalez; Pierre Paradis; Ernesto L Schiffrin
Journal:  Cardiovasc Res       Date:  2012-12-17       Impact factor: 10.787

Review 5.  Cellular and molecular mechanisms of pain.

Authors:  Allan I Basbaum; Diana M Bautista; Grégory Scherrer; David Julius
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

6.  Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle.

Authors:  Christopher J Pelham; Henry L Keen; Steven R Lentz; Curt D Sigmund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-27       Impact factor: 3.619

7.  PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.

Authors:  Pimonrat Ketsawatsomkron; Ramón A Lorca; Henry L Keen; Eric T Weatherford; Xuebo Liu; Christopher J Pelham; Justin L Grobe; Frank M Faraci; Sarah K England; Curt D Sigmund
Journal:  Circ Res       Date:  2012-09-07       Impact factor: 17.367

8.  Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.

Authors:  Christopher J Pelham; Pimonrat Ketsawatsomkron; Séverine Groh; Justin L Grobe; Willem J de Lange; Stella-Rita C Ibeawuchi; Henry L Keen; Eric T Weatherford; Frank M Faraci; Curt D Sigmund
Journal:  Cell Metab       Date:  2012-10-03       Impact factor: 27.287

9.  Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension.

Authors:  Carmen M Halabi; Andreas M Beyer; Willem J de Lange; Henry L Keen; Gary L Baumbach; Frank M Faraci; Curt D Sigmund
Journal:  Cell Metab       Date:  2008-03       Impact factor: 27.287

10.  PPARγ in vagal neurons regulates high-fat diet induced thermogenesis.

Authors:  Chen Liu; Angie L Bookout; Syann Lee; Kai Sun; Lin Jia; Charlotte Lee; Swalpa Udit; Yingfeng Deng; Philipp E Scherer; David J Mangelsdorf; Laurent Gautron; Joel K Elmquist
Journal:  Cell Metab       Date:  2014-04-01       Impact factor: 27.287

View more
  8 in total

Review 1.  Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.

Authors:  Pimonrat Ketsawatsomkron; Curt D Sigmund
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-03       Impact factor: 2.894

Review 2.  PPARγ Regulation in Hypertension and Metabolic Syndrome.

Authors:  Madeliene Stump; Masashi Mukohda; Chunyan Hu; Curt D Sigmund
Journal:  Curr Hypertens Rep       Date:  2015-12       Impact factor: 5.369

3.  Protective Role for Tissue Inhibitor of Metalloproteinase-4, a Novel Peroxisome Proliferator-Activated Receptor-γ Target Gene, in Smooth Muscle in Deoxycorticosterone Acetate-Salt Hypertension.

Authors:  Pimonrat Ketsawatsomkron; Henry L Keen; Deborah R Davis; Ko-Ting Lu; Madeliene Stump; T Michael De Silva; Aline M Hilzendeger; Justin L Grobe; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2015-11-23       Impact factor: 10.190

4.  Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.

Authors:  Chunyan Hu; Ko-Ting Lu; Masashi Mukohda; Deborah R Davis; Frank M Faraci; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2015-11-03       Impact factor: 3.107

5.  EP3 (E-Prostanoid 3) Receptor Mediates Impaired Vasodilation in a Mouse Model of Salt-Sensitive Hypertension.

Authors:  Jing Wu; Shi Fang; Ko-Ting Lu; Kelsey Wackman; Michal L Schwartzman; Sergey I Dikalov; Justin L Grobe; Curt D Sigmund
Journal:  Hypertension       Date:  2021-03-01       Impact factor: 9.897

6.  Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension.

Authors:  Jing Wu; Larry N Agbor; Shi Fang; Masashi Mukohda; Anand R Nair; Pablo Nakagawa; Avika Sharma; Donald A Morgan; Justin L Grobe; Kamal Rahmouni; Robert M Weiss; James A McCormick; Curt D Sigmund
Journal:  Cardiovasc Res       Date:  2021-01-01       Impact factor: 13.081

7.  Calcium/calmodulin-dependent kinase II inhibition in smooth muscle reduces angiotensin II-induced hypertension by controlling aortic remodeling and baroreceptor function.

Authors:  Anand M Prasad; Donald A Morgan; Daniel W Nuno; Pimonrat Ketsawatsomkron; Thomas B Bair; Ashlee N Venema; Megan E Dibbern; William J Kutschke; Robert M Weiss; Kathryn G Lamping; Mark W Chapleau; Curt D Sigmund; Kamal Rahmouni; Isabella M Grumbach
Journal:  J Am Heart Assoc       Date:  2015-06-15       Impact factor: 5.501

8.  Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.

Authors:  Maria Alicia Carrillo-Sepulveda; Henry L Keen; Deborah R Davis; Justin L Grobe; Curt D Sigmund
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.